Perspective Therapeutics, Inc. short interest in 2025
In 2025, Perspective Therapeutics, Inc.'s disclosed short interest ran from 11.29% of shares outstanding on 15 Jan 2025 to 11.49% on 31 Dec 2025, a change of +0.20 percentage points. The year's high was 11.49% on 15 Dec 2025 and its low 6.78% on 15 Apr 2025, averaging 8.71% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.46 days on 14 Mar 2025. Full history: Perspective Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 11.29% (15 Jan 2025)
- End of year
- 11.49% (31 Dec 2025)
- Change
- +0.20 pp
- High
- 11.49% (15 Dec 2025)
- Low
- 6.78% (15 Apr 2025)
- Average
- 8.71%
- Highest days to cover
- 11.46 (14 Mar 2025)
- SEC filings marked
- 10
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 11.29% | 6.37 | results (8-K) |
| 31 Jan 2025 | 8.02% | 4.98 | |
| 14 Feb 2025 | 8.11% | 9.90 | |
| 28 Feb 2025 | 8.74% | 9.17 | |
| 14 Mar 2025 | 8.79% | 11.46 | |
| 31 Mar 2025 | 7.71% | 8.93 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 6.78% | 4.32 | |
| 30 Apr 2025 | 7.11% | 7.65 | |
| 15 May 2025 | 7.64% | 9.58 | 10-Q filed, results (8-K) |
| 30 May 2025 | 7.13% | 5.97 | |
| 13 Jun 2025 | 7.58% | 2.70 | |
| 30 Jun 2025 | 8.43% | 3.76 | |
| 15 Jul 2025 | 8.57% | 5.38 | |
| 31 Jul 2025 | 8.77% | 8.44 | |
| 15 Aug 2025 | 8.46% | 9.38 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 8.58% | 10.65 | |
| 15 Sep 2025 | 8.98% | 8.16 | |
| 30 Sep 2025 | 9.12% | 8.24 | |
| 15 Oct 2025 | 8.74% | 4.73 | |
| 31 Oct 2025 | 8.86% | 3.66 | results (8-K) |
| 14 Nov 2025 | 9.04% | 3.31 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 9.62% | 3.59 | |
| 15 Dec 2025 | 11.49% | 5.01 | |
| 31 Dec 2025 | 11.49% | 8.08 |
See also: Perspective Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.